NovoCure Limited Stock-Based Compensation
NovoCure Limited (NVCR) reported Stock-Based Compensation of $17.01 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-23.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-07-23
- NovoCure Limited share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $17.01M, a 34.93% decline year-over-year.
- NovoCure Limited share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $63.01M, a 113.21% increase year-over-year.
- NovoCure Limited share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $19.82M, a 68.42% decline year-over-year.
- NovoCure Limited share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $29.32M, a 6.51% decline year-over-year.
- NovoCure Limited share-based payment arrangement, noncash expense for fiscal 2024 was $160.03M, a 38.43% increase from fiscal 2023.
- NovoCure Limited share-based payment arrangement, noncash expense for fiscal 2023 was $115.61M, a 8.09% increase from fiscal 2022.
- NovoCure Limited share-based payment arrangement, noncash expense for fiscal 2022 was $106.95M, a 12.70% increase from fiscal 2021.
- NovoCure Limited share-based payment arrangement, noncash expense for fiscal 2021 was $94.90M, a 25.33% increase from fiscal 2020.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $17.01M 10-Q · filed 2026-07-23 | $80.02M 10-Q · filed 2026-07-23 | $99.84M derived: sum of 3 quarters · filed 2026-07-23 | $129.16M derived: sum of 4 quarters · filed 2026-07-23 |
| 2026-03-31 | $63.01M 10-Q · filed 2026-04-30 | $82.83M derived: sum of 2 quarters · filed 2026-07-23 | $112.15M derived: sum of 3 quarters · filed 2026-07-23 | $138.29M derived: sum of 4 quarters · filed 2026-07-23 |
| 2025-12-31 | $19.82M derived: 10-Q 12 month − 10-Q 9 month · filed 2026-07-23 | $49.14M derived: sum of 2 quarters · filed 2026-07-23 | $75.28M derived: sum of 3 quarters · filed 2026-07-23 | $104.83M 10-Q · filed 2026-07-23 |
| 2025-09-30 | $29.32M 10-Q · filed 2025-10-30 | $55.46M derived: sum of 2 quarters · filed 2026-07-23 | $85.02M 10-Q · filed 2025-10-30 | $147.77M derived: sum of 4 quarters · filed 2026-07-23 |
| 2025-06-30 | $26.14M 10-Q · filed 2026-07-23 | $55.70M 10-Q · filed 2026-07-23 | $118.45M derived: sum of 3 quarters · filed 2026-07-23 | $149.82M derived: sum of 4 quarters · filed 2026-07-23 |
| 2025-03-31 | $29.55M 10-Q · filed 2026-04-30 | $92.31M derived: sum of 2 quarters · filed 2026-04-30 | $123.67M derived: sum of 3 quarters · filed 2026-04-30 | $155.50M derived: sum of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | $62.76M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $94.12M derived: sum of 2 quarters · filed 2026-02-26 | $125.95M derived: sum of 3 quarters · filed 2026-02-26 | $160.03M 10-K · filed 2026-02-26 |
| 2024-09-30 | $31.36M 10-Q · filed 2025-10-30 | $63.19M derived: sum of 2 quarters · filed 2025-10-30 | $97.28M 10-Q · filed 2025-10-30 | $114.72M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $31.83M 10-Q · filed 2025-07-24 | $65.91M 10-Q · filed 2025-07-24 | $83.35M derived: sum of 3 quarters · filed 2026-02-26 | $109.70M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $34.08M 10-Q · filed 2025-04-24 | $51.52M derived: sum of 2 quarters · filed 2026-02-26 | $77.87M derived: sum of 3 quarters · filed 2026-02-26 | $110.61M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $17.44M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $43.78M derived: sum of 2 quarters · filed 2026-02-26 | $76.52M derived: sum of 3 quarters · filed 2026-02-26 | $115.61M 10-K · filed 2026-02-26 |
| 2023-09-30 | $26.35M 10-Q · filed 2024-10-30 | $59.09M derived: sum of 2 quarters · filed 2024-10-30 | $98.17M 10-Q · filed 2024-10-30 | $127.95M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $32.74M 10-Q · filed 2024-07-25 | $71.82M 10-Q · filed 2024-07-25 | $101.61M derived: sum of 3 quarters · filed 2025-02-27 | $127.91M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $39.08M 10-Q · filed 2024-05-02 | $68.87M derived: sum of 2 quarters · filed 2025-02-27 | $95.17M derived: sum of 3 quarters · filed 2025-02-27 | $120.99M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $29.78M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $56.09M derived: sum of 2 quarters · filed 2025-02-27 | $81.91M derived: sum of 3 quarters · filed 2025-02-27 | $106.95M 10-K · filed 2025-02-27 |
| 2022-09-30 | $26.30M 10-Q · filed 2023-10-26 | $52.13M derived: sum of 2 quarters · filed 2023-10-26 | $77.17M 10-Q · filed 2023-10-26 | $99.57M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-06-30 | $25.82M 10-Q · filed 2023-07-27 | $50.87M 10-Q · filed 2023-07-27 | $73.27M derived: sum of 3 quarters · filed 2024-02-22 | $99.02M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-03-31 | $25.05M 10-Q · filed 2023-05-04 | $47.44M derived: sum of 2 quarters · filed 2024-02-22 | $73.20M derived: sum of 3 quarters · filed 2024-02-22 | $101.08M derived: sum of 4 quarters · filed 2024-02-22 |
| 2021-12-31 | $22.40M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $48.16M derived: sum of 2 quarters · filed 2024-02-22 | $76.04M derived: sum of 3 quarters · filed 2024-02-22 | $94.90M 10-K · filed 2024-02-22 |
| 2021-09-30 | $25.76M 10-Q · filed 2022-10-27 | $53.64M derived: sum of 2 quarters · filed 2022-10-27 | $72.50M 10-Q · filed 2022-10-27 | $92.78M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | $27.88M 10-Q · filed 2022-07-28 | $46.74M 10-Q · filed 2022-07-28 | $67.02M derived: sum of 3 quarters · filed 2023-02-23 | $87.14M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | $18.86M 10-Q · filed 2022-04-28 | $39.14M derived: sum of 2 quarters · filed 2023-02-23 | $59.26M derived: sum of 3 quarters · filed 2023-02-23 | $78.03M derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | $20.27M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $40.39M derived: sum of 2 quarters · filed 2023-02-23 | $59.16M derived: sum of 3 quarters · filed 2023-02-23 | $75.72M 10-K · filed 2023-02-23 |
| 2020-09-30 | $20.12M 10-Q · filed 2021-10-28 | $38.89M derived: sum of 2 quarters · filed 2021-10-28 | $55.45M 10-Q · filed 2021-10-28 | $70.14M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-06-30 | $18.77M 10-Q · filed 2021-07-29 | $35.33M 10-Q · filed 2021-07-29 | $50.02M derived: sum of 3 quarters · filed 2022-02-24 | $64.36M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-03-31 | $16.56M 10-Q · filed 2021-04-29 | $31.25M derived: sum of 2 quarters · filed 2022-02-24 | $45.59M derived: sum of 3 quarters · filed 2022-02-24 | $59.32M derived: sum of 4 quarters · filed 2022-02-24 |
| 2019-12-31 | $14.70M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $29.04M derived: sum of 2 quarters · filed 2022-02-24 | $42.77M derived: sum of 3 quarters · filed 2022-02-24 | $52.42M 10-K · filed 2022-02-24 |
| 2019-09-30 | $14.34M 10-Q · filed 2020-10-29 | $28.07M derived: sum of 2 quarters · filed 2020-10-29 | $37.72M 10-Q · filed 2020-10-29 | $48.36M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $13.73M 10-Q/A · filed 2020-10-02 | $23.38M 10-Q/A · filed 2020-10-02 | $34.02M derived: sum of 3 quarters · filed 2021-02-25 | $44.50M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $9.65M 10-Q/A · filed 2020-10-02 | $20.29M derived: sum of 2 quarters · filed 2021-02-25 | $30.77M derived: sum of 3 quarters · filed 2021-02-25 | $40.98M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | $10.64M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $21.12M derived: sum of 2 quarters · filed 2021-02-25 | $31.33M derived: sum of 3 quarters · filed 2021-02-25 | $39.85M 10-K · filed 2021-02-25 |
| 2018-09-30 | $10.48M 10-Q · filed 2019-10-31 | $20.68M derived: sum of 2 quarters · filed 2019-10-31 | $29.20M 10-Q · filed 2019-10-31 | $35.56M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-06-30 | $10.21M 10-Q · filed 2019-07-25 | $18.73M 10-Q · filed 2019-07-25 | $25.08M derived: sum of 3 quarters · filed 2020-02-27 | $33.71M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-03-31 | $8.52M 10-Q · filed 2019-05-02 | $14.88M derived: sum of 2 quarters · filed 2020-02-27 | $23.50M derived: sum of 3 quarters · filed 2020-02-27 | $31.07M derived: sum of 4 quarters · filed 2020-02-27 |
| 2017-12-31 | $6.36M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $14.98M derived: sum of 2 quarters · filed 2020-02-27 | $22.55M derived: sum of 3 quarters · filed 2020-02-27 | $27.12M 10-K · filed 2020-02-27 |
| 2017-09-30 | $8.63M 10-Q · filed 2018-10-25 | $16.20M derived: sum of 2 quarters · filed 2018-10-25 | $20.76M 10-Q · filed 2018-10-25 | $26.18M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-06-30 | $7.57M 10-Q · filed 2018-07-26 | $12.13M 10-Q · filed 2018-07-26 | $17.55M derived: sum of 3 quarters · filed 2019-02-28 | $23.18M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-03-31 | $4.56M 10-Q · filed 2018-04-26 | $9.98M derived: sum of 2 quarters · filed 2019-02-28 | $15.61M derived: sum of 3 quarters · filed 2019-02-28 | $21.24M derived: sum of 4 quarters · filed 2019-02-28 |
| 2016-12-31 | $5.42M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $11.05M derived: sum of 2 quarters · filed 2019-02-28 | $16.68M derived: sum of 3 quarters · filed 2019-02-28 | $22.14M 10-K · filed 2019-02-28 |
| 2016-09-30 | $5.63M 10-Q · filed 2017-10-26 | $11.26M derived: sum of 2 quarters · filed 2017-10-26 | $16.72M 10-Q · filed 2017-10-26 | $21.21M derived: sum of 4 quarters · filed 2018-02-22 |
| 2016-06-30 | $5.64M 10-Q · filed 2017-07-27 | $11.09M 10-Q · filed 2017-07-27 | $15.58M derived: sum of 3 quarters · filed 2018-02-22 | $18.51M derived: sum of 4 quarters · filed 2018-02-22 |
| 2016-03-31 | $5.46M 10-Q · filed 2017-04-27 | $9.94M derived: sum of 2 quarters · filed 2018-02-22 | $12.87M derived: sum of 3 quarters · filed 2018-02-22 | $15.50M derived: sum of 4 quarters · filed 2018-02-22 |
| 2015-12-31 | $4.49M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-22 | $7.42M derived: sum of 2 quarters · filed 2018-02-22 | $10.05M derived: sum of 3 quarters · filed 2018-02-22 | $11.86M 10-K · filed 2018-02-22 |
| 2015-09-30 | $2.93M 10-Q · filed 2016-11-02 | $5.56M derived: sum of 2 quarters · filed 2016-11-02 | $7.37M 10-Q · filed 2016-11-02 | $8.64M derived: sum of 4 quarters · filed 2017-02-23 |
| 2015-06-30 | $2.63M 10-Q · filed 2016-07-28 | $4.44M 10-Q · filed 2016-07-28 | $5.71M derived: sum of 3 quarters · filed 2017-02-23 | |
| 2015-03-31 | $1.81M 10-Q · filed 2016-05-10 | $3.08M derived: sum of 2 quarters · filed 2017-02-23 | ||
| 2014-12-31 | $1.27M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | $4.62M 10-K · filed 2017-02-23 | ||
| 2014-09-30 | $3.35M 10-Q · filed 2015-10-27 | |||
| 2013-12-31 | $5.12M 10-K · filed 2016-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |